• Acino in Latin America
    • Company Profile
    • Our Culture
    • Our Management
    • Our History
  • Services
    • We Partner
    • We Market
  • Products
  • We Care
  • Media
  • Careers
  • Contact Us
Portuguese (Brazil)Spanish
  • Acino in Latin America
    • Company Profile
    • Our Culture
    • Our Management
    • Our History
  • Services
    • We Partner
    • We Market
  • Products
  • We Care
  • Media
  • Careers
  • Contact Us

We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on “Accept All”, you consent to the processing of data by Acino and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on “Confirm”. Find detailed information and modify your preferences at any time in our Privacy Notice.

Necessary Cookies Always Active

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics Cookies

We would like to set Google Analytics cookies to help us analyse the traffic on our website.

11.03.2026

Notice Regarding Theft of Medication March 23, 2025

Dear customers and healthcare professionals, our top priority is to ensure the quality, efficacy, and safety of those who use...

11.03.2026

Notice Regarding Theft of Medication May 18, 2025

Dear customers and healthcare professionals, our top priority is to ensure the quality, efficacy, and safety of those who use...

05.02.2026

Notice of Temporary Suspension of Imports for the Medications Haldol (haloperidol) and Haldol Decanoate(haloperidol decanoate)

In accordance with Resolution RDC No. 18/2014, issued by Anvisa (the Brazilian Health Regulatory Agency), the company Moksha8 Brasil Indústria...

31.12.2025

Report on Transparency and Pay Equity Between Women and Men

13.11.2025

Notice of Registration Cancellation for the Drug Ultraproct LDO (fluocortolone pivalate, lidocaine hydrochloride)

In accordance with Resolution RDC No. 18/2014, issued by Anvisa (the Brazilian Health Regulatory Agency), Moksha8 Brasil Indústria e Comércio...

02.09.2025

Cargo Theft Alert: NABOTA® 100U – Lot X25025

06.01.2025

Notice of Lisodren’s Registration Cancellation

Moksha8 Brasil Indústria e Comércio de Medicamentos Ltda (“M8 Pharmaceuticals”) announces that on May 7, 2024, it requested that the...

02.12.2024

Leadership Announcements and New Arcera Structure

Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...

01.10.2024

Acino Publishes Second Annual Sustainability Report

Report underscores Acino’s continued commitment to Environmental, Social, and Governance goals, including a firm commitment to reaching full carbon neutrality...

Contact UsReport an Adverse Event
Acino - Part of Arcera
  • Acino in Latin America
  • Company Profile
  • Our Culture
  • Our Management
  • Our History
  • Services
  • We Partner
  • We Market
  • Products
  • We Care

  • Privacy
  • Terms of Use
  • Social Media Community Guidelines
Back to top

© 2026 Acino Latinoamericana S.A.

This site is intended for audiences in Latin America and provides general information about our products to a wide range of consumers. Some content may not be available or applicable in your country. Please note that we are not responsible for your access to such content. For country-specific information, we recommend consulting your local regulatory authorities. For medical advice, always seek guidance from a qualified healthcare professional.